CAS: 51762-05-1; Cefroxadine

该化合物是一种半合成抗生素,属于甲状腺素类,专门设计用于防治细菌感染,它针对各种克格朗阳性细菌和一些克格拉姆阴性细菌,有广泛的活动,能够有效地治疗呼吸道感染,皮肤感染和其他细菌疾病;Cefroxadine通过抑制细菌细胞壁合成,导致细胞分解和死亡,进行工作,该化合物一般是口服,在胃肠道中吸收良好;其药用植物包括相对短的半衰期,需要全天多剂量才能保持治疗水平;常见副作用可能包括胃肠扰动,过敏反应,在稀有的情况下,包括更严重的超敏反应;与其他抗药剂一样,抗药的出现也令人关切,突出了适当使用的重要性;Cefroxadine由于可获得新的抗生素,其功效和安全特征得到提高,通常不作为第一线治疗.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

7-氨基-3-甲氧基-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸 7-Amino-3-Methoxy-3-Cephem-4-Carboxylic Acid 51803-38-4

合成工艺路线路线简述

    2-(Cyclohexa-1,4-Dien-1-yl)-2-((4-Methoxy-4-Oxobutan-2-Ylidene)Amino)Acetic Pivalic Anhydride,7-氨基-3-甲氧基-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸置于二异丙胺体系中,用 二氯甲烷,二甲基亚砜 作为反应溶剂,化学反应 3.17H,反应生成 头孢沙定
    参考文献:세프록사딘의 제조방법
    标题:세프록사딘의 제조방법
    摘要:一种制备口服抗生素cefpodoxime的新方法被发明.制备cefpodoxime的方法包括以下步骤:在有机溶剂n-丁基醋酸酯中,将2-(环己烯-1,4-二烯-1-基)-2-(4-甲氧基-4-氧代丁基)氨基乙酸钠与对苯二酚酯反应,制备2-(环己烯-1,4-二烯-1-基)-2-(4-甲氧基-4-氧代丁基亚甲基)乙酸酐;将2-(环己烯-1,4-二烯-1-基)-2-(4-甲氧基-4-氧代丁基亚甲基)乙酸酐与7-氨基-3-甲氧基-3-头孢烷-4-羧酸反应.

    海关参考信息

    专利信息


    专利号:US-6218138-B1
    优先权日:1998-05-26
    标 题 :Synthesis of beta-lactam antibiotics with immobilized penicillin amidase
    发明人:ILHAN FERHAT; KRAEMER DIETER
    权利人:UNIFAR KIMYA SANAYI VE TICARET
    摘要:Beta-lactam antibiotics are synthesized by reacting an amino-beta-lactam component with a corresponding amino-group-containing acylating side-chain component in the presence of penicillin amidase from E. coli covalently immobilized on support particles. The resulting beta-lactam antibiotic product is solubilized by adding an acid such as sulfuric acid to lower the pH to 1.0 at a temperature in the range of 0° C. to +5° C. The immobilized penicillin amidase is substantially inactivated by the acid. After separating the beta-lactam antibiotic product, the immobilized penicillin amidase is substantially reactivated for reuse in antibiotic synthesis by treatment with a buffer having about a neutral pH. Antibiotics that can be produced include ampicillin, amoxicillin, cephalexin, cefaclor and cefadroxil. Support particles that can be used include particles having a macroporous structure and a particle diameter of 10-1000 mum, particles having oxirane groups, particles made of a synthetic polymer and inorganic particles such as porous glass particles.

    专利号:US-2018222848-A1
    优先权日:2015-08-04
    标 题:Salt of Dihydrophenylglycine Methyl Ester
    发明人:VAN DER DOES THOMAS; MOODY HAROLD MONRO; LI WEIDONG
    权利人:DSM SINOCHEM PHARM NL BV
    摘要:The present invention relates to the hemi sulfuric acid salt of methyl (R)-2-amino-2-(cyclohexa-1,4-dien-1-yl)acetate, also trivially referred to as the hemi sulfuric acid salt of D-dihydrophenylglycine methyl ester, to a method for the preparation of said salt and to the use of said salt in the enzymatic synthesis of antibiotics.

    专利号:US-8017776-B2
    优先权日:2003-07-15
    标题 :Methods for synthesis of acyloxyalkyl compounds
    发明人:BHAT LAXMINARAYAN; GALLOP MARK A
    权利人:XENOPORT INC
    摘要:Disclosed herein are methods for synthesizing 1-(acyloxy)-alkyl prodrug derivatives of drugs through oxidation of 1-acyl-alkyl derivatives of drugs under anhydrous reaction conditions. The methods typically proceed stereospecifically, in high yield, do not require the use of activated intermediates and/or toxic compounds and are readily amenable to scale-up.

    专利号:US-4340672-A
    优先权日:1979-09-19
    标 题:Enzymatic synthesis of β-lactam antibacterials
    发明人:KONDO EIJI; MITSUGI TAKASHI; FUJIWARA TAMIO; MUNEYUKI RYONOSUKE
    权利人:SHIONOGI & CO
    摘要:Penicillins and cephalosporins can be synthesized by the action of an acylase on a penicillin or cephalosporin nucleus amine as substrate and an ester (I) of the following formula as the acyl source: (I) (wherein RCO is an acyl group in penicillin or cephalosporin side chains; X is a hydrogen atom, lower alkyl group or hydroxy-lower alkyl group; Y is a hydrogen atom or a lower alkyl group; and n is a positive integer). The novel acyl source (I) is also disclosed.

    专利号:US-9693999-B2
    优先权日:2011-01-26
    标题:Small molecule RNase inhibitors and methods of use
    发明人:DUNMAN PAUL M; OLSON PATRICK D; CHILDERS WAYNE
    权利人:UNIV ROCHESTER; UNIV NEBRASKA; Temple University—Of the Commonwealth System of Higher Education
    摘要:Small molecule inhibitors of bacterial ribonuclease (e.g., RnpA) and methods for their synthesis and use are described herein. The methods of using the compounds include treating and preventing microbial infections and inhibiting bacterial ribonuclease. Also described herein are methods of identifying compounds for treating or preventing a microbial infection.

    专利号:US-8143437-B2
    优先权日:2002-02-19
    标题:Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
    发明人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X
    权利人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X; XENOPORT INC
    摘要:The present invention provides a method for synthesizing 1-(acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amendable to scale-up. The current invention also provides 1-acyl-alkyl derivatives of known drug components and methods for synthesizing these 1-acyl-alkyl derivatives.
    台州市新星医药化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.nova-mc.com
    企业联系电话:0576-84288698👤
    📞台州市新星医药化工有限公司 ⚠️参考联系方式
    联系人:张先生
    电话:0576-84288698
    手机:13906582100
    传真:0576-85691000
    邮箱:lhxxhgc@mail.tzptt.zj.cn
    通信地址: 台州临海沿江化工区
    邮编: 317022
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:台州临海沿江化工区
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    浙江华方药业股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.huafangpharm.com
    企业联系电话:0576-84169890,84172638👤
    📞浙江华方药业股份有限公司 ⚠️参考联系方式
    联系人:徐先生
    电话:0576-84169890,84172638
    手机:13857636664
    传真:0576-84179781
    邮箱:xck@huafangpharm.com
    通信地址: 浙江黄岩经济开发区轻化投资区(江口)大闸路10号
    邮编: 318020
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江黄岩经济开发区轻化投资区(江口)大闸路10号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Kang YS, Lee SY, Kim NH, Choi HM, Park JS, Kim W, Lee HJ. A specific and rapid HPLC assay for the determination of cefroxadine in human plasma and its application to pharmacokinetic study in Korean. J Pharm Biomed Anal. 2006 Feb 13;40(2):369-74. Epub 2005 Aug 30. Japanese. Japanese. Japanese. Italian. Japanese. Japanese. Japanese.

    合成参考文献


    摘要:Drugs in Japan, -(689), 1995
    参考文献:10.2165/00003495-199753010-00006
    摘要:Scaglione F, Demartini G, Arcidiacono MM, Pintucci JP. Optimum treatment of streptococcal pharyngitis. Drugs. 1997 Jan;53(1):86–97. doi: 10.2165/00003495-199753010-00006.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知